Introduction
One of the key regulators of the apoptotic response to DNA-damaging agents is the tumor suppressor p53. When a cell's DNA is damaged, the levels of p53 protein rise (Maltzman and Czyzyk, 1984; Kastan et al., 1991) and either apoptosis or growth arrest occurs (Yonish-Rouach et al., 1991; Kastan et al., 1992; Lowe et al., 1993; Clarke et al., 1993) . Exactly how p53 elicits this response in the cell is currently unknown, but one candidate mechanism resides in p53's ability to stimulate the transcription of a battery of genes (reviewed in Gottlieb and Oren, 1996; Ko and Prives, 1996) . The question now being examined is whether, and if so, how these targets of p53 determine the apoptotic response of the cell to DNA damage.
Transcriptional targets of p53 include the gene p21 WAF1/CIP1 (p21) (El-Deiry et al., 1993) , which encodes a protein that functions as a cell cycle inhibitor by complexing with and inactivating cyclin-dependent kinase complexes (Harper et al., 1993; Xiong et al., 1993) . Overexpression of p21 inhibits cell growth by causing cell cycle arrest (El-Deiry et al., 1993) as well as having a potential role in regulating DNA replication and repair (Li et al., 1994; Waga et al., 1994) . There does not seem to be a requirement for p21 in promoting p53-dependent apoptosis, as mice harboring mutant p21 alleles are competent in this process (Deng et al., 1995; Brugarolas et al., 1995) . An additional p53-responsive target probably involved in cell cycle regulation is cyclin G, although its exact function is unknown (Okamoto and Beach, 1994; Zauberman et al., 1995) .
Another gene activated by p53 is mdm2, which actually encodes an inhibitor of p53 transactivation (Momand et al., 1992; Barak et al., 1993; Wu et al., 1993b) . The p53-dependent activation of an inhibitor of p53 thereby creates a feedback loop to regulate p53 function. mdm2 is an oncogene, as it has been shown to promote cellular transformation (Fakharzadeh et al., 1991; Finlay, 1993) and be ampli®ed in human sarcomas (Oliner et al., 1992) . Deletion of the mdm2 gene in the mouse results in early embryonic lethality (Montes de Oca Luna et al., 1995; Jones et al., 1995) owing to the increased p53 activity that occurs in the absence of mdm2; mice lacking both mdm2 and p53 survive to adulthood and appear identical to mice lacking only p53 (Jones et al., 1996; McMasters et al., 1996) . Unfortunately, the mdm2-null phenotype precludes a direct analysis of the role of MDM2 in p53-dependent apoptosis.
The bax gene, a known promoter of apoptosis (Oltvai et al., 1993 ) also serves as a direct transcriptional target for p53 (Miyashita and Reed, 1995) and is induced in cells undergoing p53-mediated apoptosis (Miyashita et al., 1994; Friedlander et al., 1996; Ludwig et al., 1996) . However, mice that are mutant for the bax gene do not appear to have decreased or altered p53-dependent apoptosis (Knudson et al., 1995) , indicating that bax, like p21, is dispensable for this particular function of p53. Another potential eector of p53-mediated apoptosis is Fas, a cell surface receptor capable of inducing apoptosis (reviewed in Smith et al., 1994) . While there are no data indicating that Fas is a direct target of p53, previous reports showed that Fas expression can be increased by wild-type p53 and that increased expression correlates with the induction of apoptosis (Owen-Schaub et al., 1995; Tamura et al., 1995) . Both bax and Fas have been well-characterized as inducers of apoptosis in hematopoetic systems.
The experimental system previously utilized in studies of p53-mediated apoptosis is g-irradiation of murine thymocytes. These thymocytes exhibit p53-dependent apoptosis when treated with the DNA damaging agent ionizing radiation (Lowe et al., 1993; Clarke et al., 1993) . So far, this system has demonstrated the requirement for p53 (Lowe et al., 1993; Clarke et al., 1993) , as well as the dispensability of p21 (Deng et al., 1995; Brugarolas et al., 1995) and bax (Knudson et al., 1995) , in DNA-damage-induced apoptosis.
Understanding how the expression of p53 target genes is induced upon DNA damage and the consequences to the thymocyte system would help decipher the relevance of these targets in eecting p53 function in vivo. To that end, we irradiated thymocytes and assayed the levels of p53 target genes. We demonstrated p53-dependent, irradiation-induced increases of all tested targets. Interestingly, targets with a probable role in apoptosis did not increase as rapidly as target genes implicated in cell cycle control. We used this in vivo system to test additional target genes of p53 for their ability to aect apoptosis. Because both p21 and bax have been previously tested and shown to have no required role in vivo in p53-mediated apoptosis, it seemed more likely that other target genes, such as mdm2 or Fas, would have some consequence in this biological function. We demonstrate here using mice with mutations in Fas or mdm2, that MDM2 has no role independent of p53 in preventing apoptosis, and that Fas, like p21 and bax, is dispensable for p53-dependent apoptosis.
Results

p53-mediated apoptosis occurs in thymocytes
Previous experiments had shown a requirement for functional p53 in DNA-damage-induced apoptosis in thymocytes (Lowe et al., 1993; Clarke et al., 1993) . To ensure that such was the case in this series of experiments, the following analyses were performed. The thymocytes from either wild type or p53-de®cient mice were irradiated with 2.5 Gy (LD 50 =30 days) at various times and FACS analysis performed to determine DNA content. A basal level of *30% of cells underwent apoptosis after 24 h in the untreated wild type and mutant p53 cells (Figure 1 ). Only in cells containing wild-type p53 did this number increase to 59% upon irradiation over a 24 h time period, as has previously been shown (Lowe et al., 1993; Clarke et al., 1993) . Therefore, the apoptosis induced in these cells by ionizing radiation was dependent on functional p53.
To verify that the cells undergoing apoptosis were thymocytes, additional FACS analyses were performed. Mice were irradiated before sacri®ce and the thymocytes extracted. However, instead of PI staining, they were stained with two antibodies against CD4 and CD8, two cell surface markers. These antibodies were conjugated with the¯uorochromes phycoerythrin (PE), and¯uorescein isothiocyanate (FITC) respectively to allow detection of positive cell populations. CD4 and CD8 together distinguish the immature population of T cells, known as thymocytes, in the thymus from the stromal and dendritic cells of that organ. As can be seen in the examples in Figure 2a mice decreased only from 78% to 73% (7%). This experiment agrees with similar experiments previously performed (Lowe et al., 1993) .
p53 target activation in g-irradiated mice
The timing and extent of p53 target induction in the thymus were investigated in irradiated wild-type and p53-mutant mice. Mice 3 to 6 weeks old were irradiated with 2.5 Gy and sacri®ced 2, 4 and 6 h after irradiation. Northern analysis of the various p53 targets was then performed on total RNA extracted from the thymuses.
p21 expression was induced in this tissue within 2 h of irradiation and persisted throughout the timecourse ( Figure 3 ) in wild-type mice. Mice that were null for p53 did not demonstrate an increase in p21 mRNA.
Additionally, mdm2 expression increased slightly in response to g-irradiation, again only in the thymic RNA from mice with wild-type p53 ( Figure 3 ). Both mdm2 transcripts previously identi®ed (Barak et al., 1993) were expressed, although the 3.2 kb transcript is much more visible than the 1.8 kb transcript. The pattern of mdm2 induction was similar to p21 in that it was seen within 2 h and persists at least 6 h.
The p53 target cyclin G (Figure 3 ) was also induced in this system with kinetics similar to p21 and mdm2, and in a p53-dependent manner. As the cyclin G cDNA was obtained at a later date, a dierent nylon membrane containing the same RNA as isolated for the other targets was utilized for cyclin G analysis. This same membrane was reprobed with GAPDH to normalize RNA loading. + cells undergo apoptosis upon irradiation. Wild-type and p53 mutant mice were irradiated or not with 2.5 Gy of ionizing radiation, and then sacri®ced 12 and 24 h later. The thymocytes were extracted and stained with¯uorescence-conjugated antibodies against CD4 and CD8. FACS analysis was used to measure the percentage of cells positive for the antigens. (a) Examples of FACS data for each genotype at 24 h. Cells doubly positive for CD4 and CD8 appear in quadrant 2. (b) Graph of the percentage of total cells staining positive for CD4 and CD8 for each genotype at 12 and 24 h. Two separate experiments were averaged, with the standard error noted by the uncolored area in each bar membrane containing RNA from the same preparation was utilized for the bax hybridization, and its GAPDH control is included in the ®gure.
Finally, Fas was also tested in this system (Figure 3 ), since it previously has been shown in tissue culture to be increased when wild type p53 was overexpressed (Owen-Schaub et al., 1995; Tamura et al., 1995) . Fas expression too was induced in this in vivo system in a p53-responsive manner, initially increasing within 2 h and strengthening after 4 h. This temporal response is roughly similar to that of bax in that both genes show strong increases at the 4 h timepoint. These data provide the ®rst indication that Fas might serve as a target of p53 in vivo.
In summary, then, all target genes tested were induced in a p53-dependent manner in vivo, regardless of their supposed functions in either growth arrest or apoptosis. However, the genes noted for cell cycle regulation (p21, mdm2 and cyclin G) were all expressed within 2 h of irradiation, while those primarily involved in apoptosis (bax and Fas) were not strongly induced until 4 h after treatment.
mdm2 does not prevent apoptosis independently of p53 in thymocytes
The role of p21 and bax in promoting p53-dependent apoptosis in this system has already been tested in vivo through generation of mice mutant for those genes (Deng et al., 1995; Brugarolas et al., 1995; Knudson et al., 1995) . These experiments demonstrated that neither of these genes was required for p53 to promote apoptosis in DNA-damaged thymocytes. Therefore, it was of interest to test whether any other p53 targets, such as mdm2 or Fas, performed any role in this in vivo process.
Our laboratory has generated mice de®cient for mdm2, which exhibit a phenotype of early embryonic lethality (Montes de Oca Luna et al., 1995) . Interestingly, this phenotype is completely rescued in a mutant p53 background: live mice were obtained that were missing both p53 and mdm2 genes. These experiments provide genetic evidence for the requirement of MDM2 in negatively regulating p53 function. When MDM2 is absent, p53 is constitutively active, presumably causing growth arrest or apoptosis in the developing embryo. When functional p53 is not present, MDM2 is no longer required, and the absence of both genes then has no deleterious eects on the embryo. However, the lethality of mdm2-null embryos precludes analysis of MDM2 function in the adult mouse. Thus it remains possible that MDM2 is involved in negatively regulating apoptosis independently of p53 function in the adult (model depicted in Figure 4 ). Indeed, it is even possible that p53 promotes apoptosis by binding to MDM2 and inhibiting its ability to prevent apoptosis.
To investigate the role of MDM2 in apoptosis, we irradiated mice that were wild type for both p53 and mdm2, as well as mice that were null for p53 and , mdm2, Fas and GAPDH; cyclin G and GAPDH; and bax and GAPDH 
Fas is not required for p53-mediated apoptosis
Another potential eector in p53-dependent apoptosis is Fas. This gene mediates apoptosis in T cells (mature thymocytes). Because it is responsive to p53 in tissue culture (Owen-Schaub et al., 1995; Tamura et al., 1995) and in vivo (this study, Figure 3) , it was possible that p53 utilized Fas to induce apoptosis in response to ionizing radiation. This possibility was tested in mice without a functional Fas gene, known as lpr mice. These mice contain two copies of a mutant Fas allele generated naturally through a transposon-like insertion that truncates the transcript, rendering it non-functional (Wu et al., 1993a) . Phenotypically, lpr mice exhibit a lymphoproliferative disorder at 3 ± 4 months of age (Watanabe-Fukunaga et al., 1992). Six-week-old mice homozygous for the lpr mutation were tested in the thymocyte apoptosis assay for comparison with wild-type mice of the same strain. As can be seen in Figure 6 , the lpr mice were fully capable of undergoing apoptosis in response to DNA damage as were wild-type mice. Thus, like bax and p21, Fas is not required for p53-mediated apoptosis in thymocytes.
Discussion
When DNA double-strand breaks are created by ionizing radiation in thymocytes, p53 responds by inducing apoptosis. We demonstrated p53-mediated apoptosis in thymocytes sustaining DNA damage with ionizing radiation, as had been shown before (Lowe et al., 1993; Clarke et al., 1993) . Two dierent FACS analyses were performed with either DNA stained with propidium iodide or cell surface markers speci®c to thymocytes stained with¯uorescing antibodies. In both methods, apoptosis was clearly seen to occur in a p53-dependent manner in cells carefully de®ned as thymocytes. These data provide independent verification of earlier experiments and demonstrate the requirement for p53 in promoting apoptosis following radiation-induced damage. Although the dose used in Figure 4 Model for mdm2 prevention of apoptosis. MDM2 protein might prevent apoptosis through a mechanism independent of p53. The ability of p53 to promote apoptosis might be through the binding and inactivation of an MDM2 inhibitory function , mdm2 +/7 (~); p53 7/7 , mdm2 7/7 (6). The thymocytes from these mice were placed in culture and irradiated with 2.5 Gy at the appropriate time. The cells were then collected, ®xed, stained with PI, and subjected to FACS analysis. This graph represents the percentage of apoptotic cells of each genotype over the 24 h timecourse Figure 6 Fas is not required for p53-mediated apoptosis in thymocytes. Wild-type mice and mice mutant (lpr/lpr) for the Fas gene were sacri®ced and their thymocytes treated as described for Figure 1 . The graph depicts the percentage of apoptotic cells of each genotype this instance (2.5 Gy) was half that used in previous experiments (Lowe et al., 1993) , the amounts of apoptosis were startlingly similar. This fact indicates that the percentage of cells undergoing apoptosis at doses between 2.5 ± 5 Gy is not necessarily dosedependent; possibly, a threshold for initiation of apoptosis has been exceeded.
Investigation of the p53 targets in this system revealed several interesting facts about the response of these targets in vivo. p21 is induced in a p53-dependent manner within 2 h of irradiation, although the cells were not cycling and therefore did not need to undergo the growth arrest typically induced by p21. As p21 has no required role in apoptosis regulated by p53 (Deng et al., 1995; Brugarolas et al., 1995) , why p21 would be induced is unclear. It is possible that the reported, though somewhat disputed, role of p21 in DNA repair through interaction with PCNA is utilized at this point (Li et al., 1994; Pan et al., 1995) . mdm2 transcripts were also induced to some extent by irradiation in a p53-dependent manner. The role of MDM2 in these thymocytes is also questionable, as its known function is that of promoting cellular proliferation through p53 inactivation, and thymocytes are either quiescent or undergoing apoptosis in this system. Additionally, as no function has been identi®ed for cyclin G, the signi®cance of its induction is currently unknown.
The kinetics of expression of the apoptosis inducers bax and Fas diered from that of the cell cycle regulatory targets p21, mdm2 and cyclin G. Strong upregulation of bax and Fas was not seen until 4 h after irradiation, compared to 2 h for the others. This dierence could be due to the particular functions of these genes. Potentially, not all the thymocytes are fated to undergo apoptosis, in which case, cell cycle regulatory proteins such as p21, MDM2 or cyclin G would still be required. Moreover, the cellular decisions made regarding the choice to undergo apoptosis might not be made until the cell`assesses' the extent of damage, leading to a delay in p53 transactivation of genes involved in that function. Also, the genes identi®ed as being promoters of apoptosis (bax and Fas) might be required later in that process, leading to the delayed expression seen in this system. In experiments with mice carrying a bax deletion, bax was shown to be dispensible for p53-mediated apoptosis (Knudson et al., 1995) . However, that does not rule out a supporting or redundant role for bax in this process.
The generation of mice de®cient for p21 or for bax has made it possible to test the required roles of these genes in the above system of thymocyte apoptosis by DNA damage. Mice with mutant p21 are incapable of fully arresting ®broblast cells in the G1 phase of the cell cycle, but the ability of thymocytes from these mice to undergo apoptosis remains intact (Deng et al., 1995; Brugarolas et al., 1995) , limiting the requisite function of p21 in the p53 pathway to that of growth arrest. Additionally, thymocytes from mice mutant for bax are not de®cient in p53-mediated apoptosis (Knudson et al., 1995) . These experiments eectively ruled out any requirement that either p21 and bax be expressed for p53 to eect the death pathway in thymocytes treated with ionizing radiation.
Other known p53 targets then become candidates in this process. In experiments outlined above, both MDM2 and Fas were tested as possible eectors for p53-induced apoptosis. Direct testing of MDM2 as a promoter of apoptosis cannot be performed, however, due to the early embryonic lethality of mdm2-null mice. Nevertheless, such a positive role for MDM2 in apoptosis seems unlikely given its accepted function: to enhance proliferation by inactivating p53 transcriptional activity. Additionally, recent experiments overexpressing mdm2 in the mammary gland did not lead to increased apoptosis (Lundgren et al., 1997) . MDM2 was more likely to have a role in preventing apoptosis, either through inactivation of p53 (still not testable) or through some other mechanism independent of p53. Indeed, we considered it possible that p53 induces apoptosis by binding to MDM2 and inactivating some apoptosis-preventing function of MDM2 (model in Figure 4 ). If such were the case, one would expect increased apoptosis in cells lacking both mdm2 and p53 in comparison with cells lacking only p53. This hypothesis was tested in irradiated thymocytes from mice containing either wild-type or mutant p53, along with wild-type, heterozygous, or mutant mdm2. From these experiments, it was apparent that loss of p53 was sucient to abolish the ability of thymocytes to undergo apoptosis and that the status of mdm2 was irrelevant in aecting this process ( Figure 5 ). These data rule out the possibility that mdm2 negatively regulates apoptosis independently of p53. It will be interesting to test whether functional p53 in the absence of mdm2 might have some eect on apoptosis in these cells. However, the means for doing such an experiment are not available at the moment.
Fas is a reasonable target through which p53 might mediate apoptosis, as it has been shown in the past to be responsive to p53 (Owen-Schaub et al., 1995; Tamura et al., 1995) , and is known to cause apoptosis in certain cell types. The ability of Fas to regulate p53-mediated apoptosis was directly testable because mice with mutant Fas alleles had been developed (WatanabeFukunaga et al., 1992; Wu et al., 1993a) . First we tested the induction of Fas in the thymocytes extracted from the p53 wild-type and mutant mice for in vivo responses. Fas RNA levels were increased by radiation in a p53-dependent manner. Ours is the ®rst evidence of p53 regulation of Fas expression in vivo. To investigate the requirement for Fas in this p53 pathway, we irradiated thymocytes from mice that were either wild type or mutant (lpr) for the Fas gene over a 24 h time period. FACS analysis was performed on these cells to measure apoptosis. We were unable to detect any dierences in apoptosis between the wild-type and lpr thymocytes, indicating that Fas is dispensable for p53-mediated apoptosis. This experiment does not prove that Fas has no role in this process, however. Indeed, additional p53 targets, either ones already identi®ed or those still unknown, might be capable of replacing either of the genes investigated in this analysis (mdm2 or Fas), or those tested earlier (p21 or bax). Detailed mating experiments between the mice of various genotypes could help to decipher the relevance of the target genes to one another in this system. In summary, investigations into the in vivo pathway of p53-mediated apoptosis have demonstrated that while the known targets of p53 tested were induced at the RNA level, none appear to be required for this process. Since the initial identi®cation of p53 as a transcription factor (Raycroft et al., 1990; Fields and Jang, 1990) , several targets of p53 have been identi®ed, yet none of these appears to contribute independently to apoptosis in vivo. This leads to certain possibilities: other unknown targets remain to be identi®ed or there is functional redundancy between the known targets. Indeed, since both bax and Fas are known inducers of apoptosis, it can easily be imagined that one might be able to compensate for the absence of the other. Another possibility that has been indicated previously in the literature is that p53 does not induce apoptosis solely through transcriptional activation of target genes but instead through some other, unknown mechanism (Caelles et al., 1994; Haupt et al., 1995; Chen et al., 1996) . The requirement for p53-mediated transactivation in inducing apoptosis in ®broblasts (Attardi et al., 1996) and BRK cells (Sabbatini et al., 1995) has been demonstrated clearly. Therefore, in this system, considering the marked transcriptional activation by p53 of known target genes and the strong correlation that exists between p53 transcriptional activation and tumor suppression, the possibility that p53-mediated transactivation is not utilized to cause apoptosis seems unlikely.
Materials and methods
Mouse breeding and genotyping
Mice of the strain 129/SvEv, harboring a single mutant p53 allele, were obtained from Jackson Laboratories (Bar Harbor, ME). A single heterozygous male was mated with a wild-type female of strain C57B1/6J. The progeny from this cross were genotyped using a PCR strategy (Livingstone et al., 1992) and those heterozygous for p53 were mated to generate mice for the p53 experiments. The mdm2 mice and PCR for genotyping were generated in our laboratory and have been described previously (Montes de Oca Luna et al., 1995) . For the Northern analysis, animals were whole-body irradiated with the indicated dose of ionizing radiation from a [
137 Cs] source. For all other experiments, unirradiated mice were sacri®ced and their thymocytes were irradiated in culture. Either wild type mice (MRL/mpj+) or homozygous mutant mice for Fas (MRL/mpj7lpr) were also obtained from Jackson Labs. These animals were sacri®ced at 4 ± 6 weeks of age.
FACS analysis on cultured thymocytes
Thymocytes harvested from unirradiated animals of the appropriate genotype were cultured at 1610 6 cells/ml in 10 ml RPMI 1640 medium (containing 25 mM HEPES) with 5% fetal bovine serum. They were cultured at 378C in 5% CO 2 for 24 h and irradiated at various times throughout that period. After irradiation, the cells were collected and centrifuged, washed in PBS and ®xed with 70% ice cold methanol overnight. Next they were centrifuged, washed in PBS, and suspended in PI buer (PBS containing 1% Tween-20, 10 mg/ml RNase and 50 mg/ ml of propidium iodide). FACS analysis was performed on a Coulter Counter EPICS Pro®le Analyser (Hialeah, FL) and cells separated by DNA content as measured by propidium iodide staining of the DNA. For the experiments that required CD4 and CD8 antibody staining, the thymocytes were cultured and treated with irradiation as above. However, after being washed in PBS, the cells were counted, and 3610 6 cells of each sample were diluted to 2 ml of PBS and recentrifuged. The cells were then resuspended in 0.5 ml of PBS with 5% BSA and 12 ml of each monoclonal antibody a-CD4 and a-CD8 (BectonDickenson) added. After a 30 min incubation at 48C in the dark, the cells were washed once in 2 ml PBS/BSA, once in PBS, and resuspended in 0.2 ml PBS containing 10 mg/ml of RNase A. FACS analysis was then performed on the cells with the two¯uorescing agents as the two gating parameters.
Northern analysis
The thymuses from sacri®ced mice were either snap frozen in liquid nitrogen and stored at 7808C until use or placed directly in guanidium thiocyanate buer and Douncehomogenized on ice for approximately 2615 s. RNA isolation was performed essentially as described (Chomczynski and Sacchi, 1987) . Ten micrograms of total RNA were run out on a 1.2% MOPS-formaldehyde gel and transferred to Hybond N + nylon membrane. This membrane was then probed sequentially with various probes. The probes were created with a random hexamerprimed labeling reaction in HEPES buer containing a-32 PdCTP. The hybridizations occurred at 428C in 50% formamide/56SSC containing 10% dextran sulfate, 0.1% SDS and 200 mg/ml of salmon sperm DNA. The membranes were washed at room temperature and at 428C in a 26 and a 0.16 SSC solution, respectively. The membranes probed with GAPDH were autoradiographed overnight; the other probes required 2 ± 5 day exposures.
